ARG1 and arthritic joint disease: L-arginine supplementation restrains inflammatory bone loss in experimental mouse arthritis and inhibits osteoclastogenesis in an ARG1-dependent manner tilting energy metabolism of inflammatory osteoclasts from glycolysis to oxidative phosphorylation [60, 141].